Entry |
|
Symbol |
Mapk12, Erk6, P38gamma, Prkm12, Sapk3
|
Name |
(RefSeq) mitogen-activated protein kinase 12
|
KO |
|
Organism |
mmu Mus musculus (house mouse)
|
Pathway |
mmu04261 | Adrenergic signaling in cardiomyocytes |
mmu04550 | Signaling pathways regulating pluripotency of stem cells |
mmu04613 | Neutrophil extracellular trap formation |
mmu04620 | Toll-like receptor signaling pathway |
mmu04621 | NOD-like receptor signaling pathway |
mmu04622 | RIG-I-like receptor signaling pathway |
mmu04625 | C-type lectin receptor signaling pathway |
mmu04658 | Th1 and Th2 cell differentiation |
mmu04660 | T cell receptor signaling pathway |
mmu04664 | Fc epsilon RI signaling pathway |
mmu04670 | Leukocyte transendothelial migration |
mmu04723 | Retrograde endocannabinoid signaling |
mmu04750 | Inflammatory mediator regulation of TRP channels |
mmu04914 | Progesterone-mediated oocyte maturation |
mmu04932 | Non-alcoholic fatty liver disease |
mmu04933 | AGE-RAGE signaling pathway in diabetic complications |
mmu04935 | Growth hormone synthesis, secretion and action |
mmu05022 | Pathways of neurodegeneration - multiple diseases |
mmu05163 | Human cytomegalovirus infection |
mmu05167 | Kaposi sarcoma-associated herpesvirus infection |
mmu05170 | Human immunodeficiency virus 1 infection |
mmu05208 | Chemical carcinogenesis - reactive oxygen species |
mmu05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer |
mmu05418 | Fluid shear stress and atherosclerosis |
|
Brite |
KEGG Orthology (KO) [BR:mmu00001]
09130 Environmental Information Processing
09132 Signal transduction
04010 MAPK signaling pathway
29857 (Mapk12)
04015 Rap1 signaling pathway
29857 (Mapk12)
04370 VEGF signaling pathway
29857 (Mapk12)
04668 TNF signaling pathway
29857 (Mapk12)
04068 FoxO signaling pathway
29857 (Mapk12)
04071 Sphingolipid signaling pathway
29857 (Mapk12)
09140 Cellular Processes
09141 Transport and catabolism
04148 Efferocytosis
29857 (Mapk12)
09143 Cell growth and death
04114 Oocyte meiosis
29857 (Mapk12)
04218 Cellular senescence
29857 (Mapk12)
09144 Cellular community - eukaryotes
04550 Signaling pathways regulating pluripotency of stem cells
29857 (Mapk12)
09150 Organismal Systems
09151 Immune system
04611 Platelet activation
29857 (Mapk12)
04613 Neutrophil extracellular trap formation
29857 (Mapk12)
04620 Toll-like receptor signaling pathway
29857 (Mapk12)
04621 NOD-like receptor signaling pathway
29857 (Mapk12)
04622 RIG-I-like receptor signaling pathway
29857 (Mapk12)
04625 C-type lectin receptor signaling pathway
29857 (Mapk12)
04660 T cell receptor signaling pathway
29857 (Mapk12)
04658 Th1 and Th2 cell differentiation
29857 (Mapk12)
04659 Th17 cell differentiation
29857 (Mapk12)
04657 IL-17 signaling pathway
29857 (Mapk12)
04664 Fc epsilon RI signaling pathway
29857 (Mapk12)
04670 Leukocyte transendothelial migration
29857 (Mapk12)
09152 Endocrine system
04912 GnRH signaling pathway
29857 (Mapk12)
04914 Progesterone-mediated oocyte maturation
29857 (Mapk12)
04917 Prolactin signaling pathway
29857 (Mapk12)
04926 Relaxin signaling pathway
29857 (Mapk12)
04935 Growth hormone synthesis, secretion and action
29857 (Mapk12)
09153 Circulatory system
04261 Adrenergic signaling in cardiomyocytes
29857 (Mapk12)
09156 Nervous system
04728 Dopaminergic synapse
29857 (Mapk12)
04723 Retrograde endocannabinoid signaling
29857 (Mapk12)
04722 Neurotrophin signaling pathway
29857 (Mapk12)
09157 Sensory system
04750 Inflammatory mediator regulation of TRP channels
29857 (Mapk12)
09158 Development and regeneration
04380 Osteoclast differentiation
29857 (Mapk12)
09159 Environmental adaptation
04714 Thermogenesis
29857 (Mapk12)
09160 Human Diseases
09161 Cancer: overview
05205 Proteoglycans in cancer
29857 (Mapk12)
05208 Chemical carcinogenesis - reactive oxygen species
29857 (Mapk12)
05235 PD-L1 expression and PD-1 checkpoint pathway in cancer
29857 (Mapk12)
09172 Infectious disease: viral
05170 Human immunodeficiency virus 1 infection
29857 (Mapk12)
05161 Hepatitis B
29857 (Mapk12)
05171 Coronavirus disease - COVID-19
29857 (Mapk12)
05163 Human cytomegalovirus infection
29857 (Mapk12)
05167 Kaposi sarcoma-associated herpesvirus infection
29857 (Mapk12)
05169 Epstein-Barr virus infection
29857 (Mapk12)
09171 Infectious disease: bacterial
05132 Salmonella infection
29857 (Mapk12)
05135 Yersinia infection
29857 (Mapk12)
05133 Pertussis
29857 (Mapk12)
05152 Tuberculosis
29857 (Mapk12)
09174 Infectious disease: parasitic
05145 Toxoplasmosis
29857 (Mapk12)
05140 Leishmaniasis
29857 (Mapk12)
05142 Chagas disease
29857 (Mapk12)
09164 Neurodegenerative disease
05014 Amyotrophic lateral sclerosis
29857 (Mapk12)
05020 Prion disease
29857 (Mapk12)
05022 Pathways of neurodegeneration - multiple diseases
29857 (Mapk12)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
29857 (Mapk12)
05418 Fluid shear stress and atherosclerosis
29857 (Mapk12)
05415 Diabetic cardiomyopathy
29857 (Mapk12)
09167 Endocrine and metabolic disease
04936 Alcoholic liver disease
29857 (Mapk12)
04932 Non-alcoholic fatty liver disease
29857 (Mapk12)
04933 AGE-RAGE signaling pathway in diabetic complications
29857 (Mapk12)
09176 Drug resistance: antineoplastic
01522 Endocrine resistance
29857 (Mapk12)
09180 Brite Hierarchies
09181 Protein families: metabolism
01001 Protein kinases [BR:mmu01001]
29857 (Mapk12)
Enzymes [BR:mmu01000]
2. Transferases
2.7 Transferring phosphorus-containing groups
2.7.11 Protein-serine/threonine kinases
2.7.11.24 mitogen-activated protein kinase
29857 (Mapk12)
Protein kinases [BR:mmu01001]
Serine/threonine kinases: CMGC group
MAPK family [OT]
29857 (Mapk12)
|
SSDB |
|
Motif |
|
Other DBs |
|
LinkDB |
|
Position |
15:complement(89014787..89025270)
|
AA seq |
367 aa
MSSPPPARKGFYRQEVTKTAWEVRAVYQDLQPVGSGAYGAVCSAVDSRTGNKVAIKKLYR
PFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDESLDDFTDFYLVMPFMGTDLGKLM
KHETLSEDRIQFLVYQMLKGLKYIHAAGVIHRDLKPGNLAVNEDCELKILDFGLARQADS
EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKILFKGNDHLDQLKEIMK
ITGTPPPEFVQKLQSAEAKNYMEGLPELEKKDFASVLTNASPQAVNLLERMLVLDAEQRV
TAAEALTHPYFESLRDTEDEPKAQKYDDSFDDVDRTLEEWKRVTYKEVLSFKPPRQLGAR
VPKETAL |
NT seq |
1104 nt +upstreamnt +downstreamnt
atgagctccccgccacccgcccgcaagggcttttaccgccaggaggtgaccaaaacggcc
tgggaggtgcgcgccgtgtaccaagacctgcagcccgttggctctggtgcctatggtgca
gtgtgctctgcagtagacagccgcactggcaacaaggtggccatcaagaagttgtaccgg
cccttccagtcggagctgtttgccaagcgcgcctacagagagttgcgcctcctcaaacac
atgcgccacgagaacgtcattgggctactggatgtgttcacacctgatgagtctctggac
gacttcacagacttctacctggtgatgccattcatgggcactgatctgggcaaactcatg
aagcatgagaccctgagtgaagacagaatccagtttcttgtgtatcagatgttgaagggg
ctgaagtatatccatgcggctggtgtcatccacagagacttgaagcctggcaacctggct
gtgaatgaggactgtgagctgaagatcctagactttggccttgccaggcaggcagacagt
gagatgacaggatatgtggtaacccggtggtatcgggcaccagaggtcatcttgaattgg
atgcgctacacgcagacagtggacatttggtccgttggctgcatcatggcggagatgatt
actgggaagatcctgttcaaaggcaatgaccacctggaccagctgaaggagatcatgaag
atcacagggacgccccctcctgagtttgttcagaagctacagagtgcagaggccaagaac
tacatggaaggcctccctgagttagaaaagaaggattttgcctctgtcctgaccaacgca
agccctcaggctgtgaatctcctggaaaggatgctggtgctggatgcggaacagcgggtg
acagcagctgaggcgttaacccatccatactttgagtcccttcgggacactgaggatgaa
cccaaggcccagaaatatgacgactcctttgatgatgtagaccgcacccttgaggaatgg
aagcgtgtgacttacaaggaagttctcagcttcaagcctcctaggcagctaggagccaga
gttccaaaggagacggctctgtga |